| Name | AZ1495 | 
|---|
| Description | AZ1495 (compound 28) is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Shows activity in treatment of mutant MYD88L265P diffuse large B-cell lymphoma (DLBCL)[1]. | 
|---|---|
| Related Catalog | |
| Target | IRAK4:5 nM (IC50) IRAK1:23 nM (IC50) CLK1:50 nM (IC50) CLK2:5 nM (IC50) CLK4:8 nM (IC50) haspin:4 nM (IC50) | 
| References | 
| Molecular Formula | C21H31N5O2 | 
|---|---|
| Molecular Weight | 385.50 | 
| Storage condition | 2-8℃ |